Jim Tananbaum, MD and the Founder and CEO of Foresite Capital, a US-focused health-care investment firm says the sector is ripe for transformation thanks to advances in AI, gene editing and new category-killers in areas like pain management and weight loss. He joined Bloomberg Open Interest to lay out his vision, and how he’s investing as President Trump’s tariff loom large over the pharma industry.
